News
Feel like you’ve missed your window of opportunity on anti-aging? This is what dermatologists say about people in their 40s ...
4hon MSN
Costs vary for the procedure, but generally start at more than $1,000 per treatment on a small area like the eyebrows and go up to more than $4,000 for the full face and neck. As Kardashian can be ...
5h
Soy Carmín on MSNSmooth Moves: Dermatologists Reveal Their Top Tips for Managing (And Preventing) Crepey SkinCrepey skin, characterized by its thin, wrinkled texture resembling crepe paper, is a common concern as we age. Fortunately, ...
Wondering how skincare actives and serums can benefit your skin? This guide explains their uses, key benefits, and which skin concerns they target.
Patients with the debilitating dermatologic condition are born with COL7A1 mutations in both gene copies, affecting the ...
In a phase 3 trial, 81% of wounds treated with autologous cell sheet-based gene therapy showed ≥ 50% healing at 6 months, ...
SHOPPING: Shoppers rave about Equi London's award-winning Beauty Formula, calling it 'the best supplement I've ever tried.' ...
Grounded Beauty's Egyptian Gold Retinol Face Serum combines high-strength retinol with hydrating hyaluronic acid to deliver ...
Persistence has paid off for Abeona Therapeutics and its gene therapy for recessive dystrophic epidermolysis bullosa (RDEB).
The FDA has approved Zevaskyn (prademagene zamikeracel) for the treatment of recessive dystrophic epidermolysis bullosa, a rare genetic skin disorder.
The US Food and Drug Administration (FDA) has approved the first cell-based gene therapy for a rare genetic skin disorder.
Additional investors include global investment firm Viking Global Investors, charity foundation CureEB, the Epidermolysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results